A new report titled “Allergy Immunotherapy Market – Forecast to 2032” by Eternal Market, the global allergy immunotherapy industry is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2032, reaching a value of USD 3.75 billion by the end of the forecast period.
Global allergy immunotherapy industry outlook
Allergy immunotherapy, commonly known as allergy injections or allergen-specific immunotherapy, is a therapeutic method used to desensitize people who are allergic to certain allergens. It is most commonly used to treat allergic diseases such hay fever (allergic rhinitis), allergic asthma, and insect venom allergies. The treatment involves regular injections of small amounts of allergens that trigger an allergic response in the individual. Over time, the dosage of the allergens is gradually increased, allowing the immune system to build up tolerance and reduce the severity of allergic reactions. The process typically takes several months to years, depending on the individual’s response. Allergy immunotherapy has been demonstrated to give long-term relief for many people, even when treatment is stopped. It can lessen the frequency and intensity of allergy symptoms, minimize the need for medication, and enhance overall quality of life.
Key Visions
- Estimated CAGR of around 6.5% over the forecast period (2023-2032).
- Global allergy immunotherapy Industry size is projected to reach USD 3.75 billion by 2032 from USD 2.55 billion in 2022.
- Advancements in treatment techniques is the key market driver.
- By type segmentation, in 2023, subcutaneous immunotherapy (SCIT) was estimated to hold largest market share.
- By distribution channel segmentation, hospital pharmacies was the largest revenue contributor.
- North America to lead the market in 2023.
Global allergy immunotherapy industry drivers
Advancements in treatment techniques may fuel the market growth.
The allergy immunotherapy market is experiencing advancements in treatment techniques, which are driving its growth and development. Innovations in treatment techniques, such as sublingual immunotherapy (SLIT) tablets and subcutaneous immunotherapy (SCIT) injections, have improved the efficacy, convenience, and patient acceptance of allergy immunotherapy. These advancements offer alternative options to traditional treatment methods, expanding the choices available to patients and healthcare providers. The development of more precise dosing protocols, improved formulations, and better administration devices has enhanced the overall effectiveness and safety of allergy immunotherapy. Advancements in treatment techniques are expected to further propel the adoption and utilization of allergy immunotherapy in the market.
Alternative treatment options
In the allergy immunotherapy market, there is a growing recognition of alternative treatment options for allergic conditions. While allergy immunotherapy is an effective and targeted approach, alternative therapies such as medications, avoidance strategies, and symptom management techniques are also available. These alternative options provide symptomatic relief and can be more easily accessible and convenient for some individuals. Additionally, advancements in pharmacotherapy, including new allergy medications, offer alternative treatment avenues. While allergy immunotherapy remains a valuable and disease-modifying option, the availability and awareness of alternative treatments provide patients with a range of choices and influence their decision-making in managing their allergies.
Integration of digital health technologies
The integration of digital health technologies, such as telemedicine, remote monitoring, and electronic health records, presents opportunities for enhancing the delivery and accessibility of allergy immunotherapy. Remote consultations, online monitoring of treatment progress, and digital platforms for patient education and support can improve patient engagement and convenience, expanding the reach of allergy immunotherapy.
Focus on convenience and patient experience
Market players are increasingly focused on improving the convenience and overall patient experience associated with allergy immunotherapy. This includes the development of user-friendly delivery systems, such as pre-filled autoinjectors or wearable devices, which enhance ease of use and adherence to treatment. Digital platforms and mobile applications that offer personalized treatment plans, remote monitoring, and educational resources are also being utilized to enhance patient engagement and satisfaction.
Global allergy immunotherapy industry segments
The global allergy immunotherapy market is segmented By Types (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), By Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Other Allergy Types) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
Based on types, in 2023, the subcutaneous immunotherapy (SCIT) segment will have the biggest share since it is the most effective and widely used kind of allergy immunotherapy. The medication is beneficial for allergic rhinitis, asthma, and stinging insect hypersensitivity. Furthermore, SCIT has been shown to be beneficial in the control of several allergens.
Based on distribution channel, in 2023, hospital pharmacy segment likely to grab the largest share. This is due to the strong reliance on government and semi-government hospitals for treatments supported by their affordability, institutional sales are anticipated to route the most income. This is partly attributable to the fact that government hospitals in developed economies offer reimbursements and supporting policies. The established firms with distribution networks, significant entry hurdles, and regulatory constraints that favor institutional sales are further reasons for the institutional sales segment’s domination of the industry.
Global allergy immunotherapy industry players
Key players operating in the global Allergy Immunotherapy market include Anergis, Circassia, Merck KGaA, Stallergenes Greer, HAL Allergy B.V., ALK Abello A/S, Allergy Therapeutics, Aimmune Therapeutics, Arrayit Corporation, Biomay AG, DBV Technologies, Aravax Pty Ltd., among others.
Industry Developments:
In July 2022, Stallergenes Greer, a global healthcare company that specializes in allergen immunotherapy (AIT), announced the positive data related to the significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis.
In March 2022, Aravax Pty Ltd announced the opening of investigational new drug (IND) application for Phase 2 clinical trials of PVX108, a next-generation immunotherapy for the treatment of peanut allergy
Major Strategies adopted by key market players
- Agreements, Collaborations, and Partnerships: 23%
- Acquisitions: 15%
- New Product Launch: _%
- Other Developments: _%
Scope of the Report:
Global Allergy Immunotherapy Market, by Type
- Sublingual Immunotherapy (SLIT)
- Subcutaneous Immunotherapy (SCIT)
Global Allergy Immunotherapy Market, by Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Other allergy types
Global Allergy Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Allergy Immunotherapy Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- India
- Japan
- Australia
- Rest of APAC (RoAPAC)
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Companies Profiled
- Anergis
- Circassia
- Merck KGaA
- Stallergenes Greer
- HAL Allergy B.V.
- ALK Abello A/S
- Allergy Therapeutics
- Aimmune Therapeutics
- Arrayit Corporation
- Biomay AG
- DBV Technologies
- Aravax Pty Ltd.
- Other Companies
*The report scope shall be customized as per the requirements
Chapter 1 Global Allergy Immunotherapy Market Overview
1.1 Introduction
1.2 Drivers for Allergy Immunotherapy Market
1.3 Restraints for Allergy Immunotherapy Market
1.4 Opportunities for Allergy Immunotherapy Market
1.5 Trends for Allergy Immunotherapy Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Allergy Immunotherapy Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Anergis
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Circassia
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Merck KGaA
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Stallergenes Greer
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 HAL Allergy B.V.
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 ALK Abello A/S
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Allergy Therapeutics
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Aimmune Therapeutics
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Arrayit Corporation
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Biomay AG
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Allergy Immunotherapy Market Overview
3.1 Global Allergy Immunotherapy Market Outlook (2017-2032)
3.1.1 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Allergy Immunotherapy Market by Region
3.2.1 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Allergy Immunotherapy Market by Type
3.3.1 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
3.3.2 Global Allergy Immunotherapy Market Attractiveness Analysis by Type, 2023–2032
3.3.3 Global Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Allergy Immunotherapy Market by Allergy Type
3.4.1 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2032)
3.4.2 Global Allergy Immunotherapy Market Attractiveness Analysis by Allergy Type, 2023–2032
3.5 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Type
3.6.1 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
3.6.2 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
3.7 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Allergy Type
3.7.1 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2023)
3.7.2 Global Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2024-2032)
3.8 Global Allergy Immunotherapy Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Allergy Immunotherapy Market Y-o-Y Growth Rate by Region
3.8.2 Global Allergy Immunotherapy Market Y-o-Y Growth Rate by Type
3.8.3 Global Allergy Immunotherapy Market Y-o-Y Growth Rate by Allergy Type
3.9 Global Allergy Immunotherapy Market Share Comparison 2017–2032
3.9.1 Global Allergy Immunotherapy Market Share by Region
3.9.2 Global Allergy Immunotherapy Market Share by Type
3.9.3 Global Allergy Immunotherapy Market Share by Allergy Type
Chapter 4 North America Allergy Immunotherapy Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Allergy Immunotherapy Market Outlook (2017-2032)
4.2.1 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Allergy Immunotherapy Market by Region
4.3.1 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Allergy Immunotherapy Market by Type
4.4.1 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
4.4.2 North America Allergy Immunotherapy Market Attractiveness Analysis by Type, 2023–2032
4.4.3 North America Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Allergy Immunotherapy Market by Allergy Type
4.5.1 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2032)
4.5.2 North America Allergy Immunotherapy Market Attractiveness Analysis by Allergy Type, 2023–2032
4.6 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Type
4.7.1 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
4.7.2 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
4.8 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Allergy Type
4.8.1 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2023)
4.8.2 North America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2024-2032)
4.9 North America Allergy Immunotherapy Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Allergy Immunotherapy Market Y-o-Y Growth Rate by Region
4.9.2 North America Allergy Immunotherapy Market Y-o-Y Growth Rate by Type
4.9.3 North America Allergy Immunotherapy Market Y-o-Y Growth Rate by Allergy Type
4.1 North America Allergy Immunotherapy Market Share Comparison 2017–2032
4.10.1 North America Allergy Immunotherapy Market Share by Region
4.10.2 North America Allergy Immunotherapy Market Share by Type
4.10.3 North America Allergy Immunotherapy Market Share by Allergy Type
Chapter 5 Europe Allergy Immunotherapy Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Allergy Immunotherapy Market Outlook (2017-2032)
5.2.1 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Allergy Immunotherapy Market by Region
5.3.1 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Allergy Immunotherapy Market by Type
5.4.1 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
5.4.2 Europe Allergy Immunotherapy Market Attractiveness Analysis by Type, 2023–2032
5.4.3 Europe Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Allergy Immunotherapy Market by Allergy Type
5.5.1 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2032)
5.5.2 Europe Allergy Immunotherapy Market Attractiveness Analysis by Allergy Type, 2023–2032
5.6 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Type
5.7.1 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
5.7.2 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
5.8 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Allergy Type
5.8.1 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2023)
5.8.2 Europe Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2024-2032)
5.9 Europe Allergy Immunotherapy Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Allergy Immunotherapy Market Y-o-Y Growth Rate by Region
5.9.2 Europe Allergy Immunotherapy Market Y-o-Y Growth Rate by Type
5.9.3 Europe Allergy Immunotherapy Market Y-o-Y Growth Rate by Allergy Type
5.1 Europe Allergy Immunotherapy Market Share Comparison 2017–2032
5.10.1 Europe Allergy Immunotherapy Market Share by Region
5.10.2 Europe Allergy Immunotherapy Market Share by Type
5.10.3 Europe Allergy Immunotherapy Market Share by Allergy Type
Chapter 6 Asia Pacific Allergy Immunotherapy Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Allergy Immunotherapy Market Outlook (2017-2032)
6.2.1 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Allergy Immunotherapy Market by Region
6.3.1 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Allergy Immunotherapy Market by Type
6.4.1 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
6.4.2 Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis by Type, 2023–2032
6.4.3 Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Allergy Immunotherapy Market by Allergy Type
6.5.1 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2032)
6.5.2 Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis by Allergy Type, 2023–2032
6.6 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Type
6.7.1 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
6.7.2 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
6.8 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Allergy Type
6.8.1 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2023)
6.8.2 Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2024-2032)
6.9 Asia Pacific Allergy Immunotherapy Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Allergy Immunotherapy Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Allergy Immunotherapy Market Y-o-Y Growth Rate by Type
6.9.3 Asia Pacific Allergy Immunotherapy Market Y-o-Y Growth Rate by Allergy Type
6.1 Asia Pacific Allergy Immunotherapy Market Share Comparison 2017–2032
6.10.1 Asia Pacific Allergy Immunotherapy Market Share by Region
6.10.2 Asia Pacific Allergy Immunotherapy Market Share by Type
6.10.3 Asia Pacific Allergy Immunotherapy Market Share by Allergy Type
Chapter 7 South America Allergy Immunotherapy Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Allergy Immunotherapy Market Outlook (2017-2032)
7.2.1 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Allergy Immunotherapy Market by Region
7.3.1 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Allergy Immunotherapy Market by Type
7.4.1 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
7.4.2 South America Allergy Immunotherapy Market Attractiveness Analysis by Type, 2023–2032
7.4.3 South America Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Allergy Immunotherapy Market by Allergy Type
7.5.1 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2032)
7.5.2 South America Allergy Immunotherapy Market Attractiveness Analysis by Allergy Type, 2023–2032
7.6 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Type
7.7.1 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
7.7.2 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
7.8 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Allergy Type
7.8.1 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2023)
7.8.2 South America Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2024-2032)
7.9 South America Allergy Immunotherapy Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Allergy Immunotherapy Market Y-o-Y Growth Rate by Region
7.9.2 South America Allergy Immunotherapy Market Y-o-Y Growth Rate by Type
7.9.3 South America Allergy Immunotherapy Market Y-o-Y Growth Rate by Allergy Type
7.1 South America Allergy Immunotherapy Market Share Comparison 2017–2032
7.10.1 South America Allergy Immunotherapy Market Share by Region
7.10.2 South America Allergy Immunotherapy Market Share by Type
7.10.3 South America Allergy Immunotherapy Market Share by Allergy Type
Chapter 8 Middle East and Africa Allergy Immunotherapy Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Allergy Immunotherapy Market Outlook (2017-2032)
8.2.1 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Allergy Immunotherapy Market by Region
8.3.1 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Allergy Immunotherapy Market by Type
8.4.1 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
8.4.2 Middle East and Africa Allergy Immunotherapy Market Attractiveness Analysis by Type, 2023–2032
8.4.3 Middle East and Africa Allergy Immunotherapy Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Allergy Immunotherapy Market by Allergy Type
8.5.1 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2032)
8.5.2 Middle East and Africa Allergy Immunotherapy Market Attractiveness Analysis by Allergy Type, 2023–2032
8.6 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Type
8.7.1 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
8.7.2 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
8.8 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) by Allergy Type
8.8.1 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2017-2023)
8.8.2 Middle East and Africa Allergy Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Allergy Type (2024-2032)
8.9 Middle East and Africa Allergy Immunotherapy Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Allergy Immunotherapy Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Allergy Immunotherapy Market Y-o-Y Growth Rate by Type
8.9.3 Middle East and Africa Allergy Immunotherapy Market Y-o-Y Growth Rate by Allergy Type
8.1 Middle East and Africa Allergy Immunotherapy Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Allergy Immunotherapy Market Share by Region
8.10.2 Middle East and Africa Allergy Immunotherapy Market Share by Type
8.10.3 Middle East and Africa Allergy Immunotherapy Market Share by Allergy Type
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources